Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response.

Saulle E, Petronelli A, Pelosi E, Coppotelli E, Pasquini L, Ilari R, Lo-Coco F, Testa U.

J Hematol Oncol. 2016 Apr 7;9:33. doi: 10.1186/s13045-016-0262-5.

2.

Regulation of S100A10 by the PML-RAR-α oncoprotein.

O'Connell PA, Madureira PA, Berman JN, Liwski RS, Waisman DM.

Blood. 2011 Apr 14;117(15):4095-105. doi: 10.1182/blood-2010-07-298851. Epub 2011 Feb 10.

3.

Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants.

Mengeling BJ, Phan TQ, Goodson ML, Privalsky ML.

J Biol Chem. 2011 Feb 11;286(6):4236-47. doi: 10.1074/jbc.M110.200964. Epub 2010 Dec 3.

4.

PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia.

Subramanyam D, Belair CD, Barry-Holson KQ, Lin H, Kogan SC, Passegué E, Blelloch R.

Cancer Res. 2010 Nov 1;70(21):8792-801. doi: 10.1158/0008-5472.CAN-08-4481. Epub 2010 Sep 21. Erratum in: Cancer Res. 2011 Apr 1;71(7):2805.

5.

A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia.

Uy GL, Lane AA, Welch JS, Grieselhuber NR, Payton JE, Ley TJ.

Blood. 2010 Nov 4;116(18):3604-10. doi: 10.1182/blood-2008-11-189282. Epub 2010 Jul 20.

6.

Design and synthesis of novel derivatives of all-trans retinoic acid demonstrate the combined importance of acid moiety and conjugated double bonds in its binding to PML-RAR-alpha oncogene in acute promyelocytic leukemia.

Schinke C, Goel S, Bhagat TD, Zhou L, Mo Y, Gallagher R, Kabalka GW, Platanias LC, Verma A, Das B.

Leuk Lymphoma. 2010 Jun;51(6):1108-14. doi: 10.3109/10428191003786766.

7.

PML/RAR-alpha fusion transcript and polyploidy in acute promyelocytic leukemia without t(15;17).

Soriani S, Cesana C, Farioli R, Scarpati B, Mancini V, Nosari A.

Leuk Res. 2010 Sep;34(9):e261-3. doi: 10.1016/j.leukres.2010.03.043. Epub 2010 Apr 24. No abstract available.

PMID:
20417966
8.

[Expression of PML-RAR alpha fusion transcripts detection by using RQ-PCR].

Han LX, Lin J, Qian J, Wang YL, Qian Z, Yang XF, Sheng XJ, Yao DM.

Zhonghua Xue Ye Xue Za Zhi. 2008 Nov;29(11):753-6. Chinese.

PMID:
19176013
9.
10.

[Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR].

Lin J, Han LX, Qian J, Wang YL, Qian Z, Yang XF, Sheng XJ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Jun;25(3):319-21. Chinese.

PMID:
18543226
11.

[Relationship between the long type PML-RAR alpha and the prognosis of patients with acute promyelocytic leukemia].

Tan YH, Wang HW, Zhang ZP, Liu W, Guo HM, Zhu L, Zhang L.

Zhonghua Xue Ye Xue Za Zhi. 2008 Jan;29(1):44-7. Chinese.

PMID:
18512315
12.

UBE1L represses PML/RAR{alpha} by targeting the PML domain for ISG15ylation.

Shah SJ, Blumen S, Pitha-Rowe I, Kitareewan S, Freemantle SJ, Feng Q, Dmitrovsky E.

Mol Cancer Ther. 2008 Apr;7(4):905-14. doi: 10.1158/1535-7163.MCT-07-0515.

13.

Real-time PCR analysis of PML-RAR alpha in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic trioxide as a front-line therapy.

Ghaffari SH, Rostami S, Bashash D, Alimoghaddam K, Ghavamzadeh A.

Ann Oncol. 2006 Oct;17(10):1553-9. Epub 2006 Jul 10.

PMID:
16831853
14.

Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.

Chan IT, Kutok JL, Williams IR, Cohen S, Moore S, Shigematsu H, Ley TJ, Akashi K, Le Beau MM, Gilliland DG.

Blood. 2006 Sep 1;108(5):1708-15. Epub 2006 May 4.

15.

Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.

Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP.

Oncogene. 2006 Mar 23;25(13):1974-9.

PMID:
16331271
16.

The co-expression of PML/RAR alpha and AML1/ETO fusion genes is associated with ATRA resistance.

Abreu e Lima RS, Baruffi MR, de Lima AS, de Oliveira FM, de Figueiredo-Pontes LL, Tone LG, Rogatto SR, Falcao RP, Ferrari Chauffaille Mde L, Rego EM.

Br J Haematol. 2005 Feb;128(3):407-9. No abstract available.

PMID:
15667548
17.

A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.

Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, Racevskis J, Dewald G, Wiernik PH, Tallman MS; Eastern Cooperative Oncology Group.

Cytometry B Clin Cytom. 2004 May;59(1):1-9.

18.

Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays.

Park DJ, Vuong PT, de Vos S, Douer D, Koeffler HP.

Blood. 2003 Nov 15;102(10):3727-36. Epub 2003 Jul 31.

19.

[DNA sequence analysis of a novel variate type of PML/RAR alpha fusion gene transcript].

Wang GP, Chen FP, Jian ZF.

Hunan Yi Ke Da Xue Xue Bao. 2001 Dec 28;26(6):581-2. Chinese. No abstract available.

PMID:
12536551
20.

C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.

Riccioni R, Saulle E, Militi S, Sposi NM, Gualtiero M, Mauro N, Mancini M, Diverio D, Lo Coco F, Peschle C, Testa U.

Leukemia. 2003 Jan;17(1):98-113.

PMID:
12529666

Supplemental Content

Loading ...
Support Center